Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Adherium Ltd. ( (AU:ADR) ) has shared an update.
Adherium Ltd. announced the issuance of 4,000,000 unquoted options set to expire on July 31, 2026, with an exercise price of $0.005. This move is part of previously announced transactions and is not intended to be quoted on the ASX, potentially impacting the company’s financial strategy and stakeholder interests by increasing its equity base.
The most recent analyst rating on (AU:ADR) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Adherium Ltd. stock, see the AU:ADR Stock Forecast page.
More about Adherium Ltd.
Adherium Ltd. operates in the healthcare industry, focusing on digital health solutions. The company specializes in developing and providing innovative technologies for respiratory care, aiming to improve patient adherence to prescribed therapies and enhance clinical outcomes.
Technical Sentiment Signal: Sell
Current Market Cap: A$9.97M
Learn more about ADR stock on TipRanks’ Stock Analysis page.